My NCBI | Sign In
RSS Settings
  • Search: Carrat Fabrice[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 51

    1.

    Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

    Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group.

    Lancet. 2009 Nov 7;374(9701):1617-25.PMID: 19837455 [PubMed - in process]Related articles

    2.

    Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study.

    Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Pol S, Halfon P.

    Antivir Ther. 2009;14(6):839-45.PMID: 19812446 [PubMed - in process]Related articles

    3.

    Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality?

    Baudel JL, Tankovic J, Carrat F, Vigneau C, Maury E, Lalande V, Guidet B, Offenstadt G.

    Ther Clin Risk Manag. 2009 Jun;5(3):491-8. Epub 2009 Jul 12.PMID: 19707259 [PubMed - in process]Related articlesFree article

    4.

    Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial.

    Lemaitre M, Meret T, Rothan-Tondeur M, Belmin J, Lejonc JL, Luquel L, Piette F, Salom M, Verny M, Vetel JM, Veyssier P, Carrat F.

    J Am Geriatr Soc. 2009 Sep;57(9):1580-6. Epub 2009 Aug 4.PMID: 19682118 [PubMed - in process]Related articles

    5.

    Mortality burden of the 1918-1919 influenza pandemic in Europe.

    Ansart S, Pelat C, Boelle PY, Carrat F, Flahault A, Valleron AJ.

    Influenza Other Respi Viruses. 2009 May;3(3):99-106.PMID: 19453486 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.

    Halfon P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Cacoub P.

    Antivir Ther. 2009;14(2):211-9.PMID: 19430096 [PubMed - indexed for MEDLINE]Related articles

    7.

    Liver fibrosis: screening is not staging.

    Bedossa P, Carrat F.

    J Hepatol. 2009 Jun;50(6):1268-9. Epub 2009 Mar 13. No abstract available. PMID: 19395116 [PubMed - indexed for MEDLINE]Related articles

    8.

    "If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoring.

    Schwarzinger M, Carrat F, Luchini S.

    J Health Econ. 2009 Jul;28(4):873-84. Epub 2009 Mar 21.PMID: 19362383 [PubMed - in process]Related articles

    9.

    Diagnosis scoring for clinical identification of children with heterozygous familial hypercholesterolemia.

    Benlian P, Turquet A, Carrat F, Amsellem S, Sanchez L, Briffaut D, Girardet JP.

    J Pediatr Gastroenterol Nutr. 2009 Apr;48(4):456-63.PMID: 19330934 [PubMed - indexed for MEDLINE]Related articles

    10.

    Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy.

    Bani-Sadr F, Lapidus N, Rosenthal E, Gerard L, Foltzer A, Perronne C, Cacoub P, Pol S, Carrat F; and the ANRS HC02-Ribavic Study Team.

    J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):429-30. No abstract available. PMID: 19322037 [PubMed - indexed for MEDLINE]Related articles

    11.

    Liver biopsy: the best, not the gold standard.

    Bedossa P, Carrat F.

    J Hepatol. 2009 Jan;50(1):1-3. Epub 2008 Nov 6. No abstract available. PMID: 19017551 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.

    Piroth L, Carrat F, Larrat S, Goderel I, Martha B, Payan C, Lunel-Fabiani F, Bani-Sadr F, Perronne C, Cacoub P, Pol S, Morand P.

    J Hepatol. 2008 Dec;49(6):892-8. Epub 2008 Jul 17.PMID: 18752863 [PubMed - indexed for MEDLINE]Related articles

    13.

    Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients.

    Carrat F, Bedossa P, Lunel-Fabiani F, Morand P, Pialoux G, Piroth L, Salmon-Céron D, Bani-Sadr F, Perronne C, Cacoub P, Pol S.

    AIDS. 2008 Jul 31;22(12):1513-5.PMID: 18614875 [PubMed - indexed for MEDLINE]Related articles

    14.

    Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.

    Bani-Sadr F, Goderel I, Lapidus N, Driss H, Simon A, Rosenthal E, Morand P, Lunel-Fabiani F, Pol S, Cacoub P, Perronne C, Carrat F; ANRS HC02 - RIBAVIC Study Team.

    AIDS. 2008 Jul 11;22(11):1385-7. No abstract available. PMID: 18580626 [PubMed - indexed for MEDLINE]Related articles

    15.

    How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited.

    Lambert J, Halfon P, Penaranda G, Bedossa P, Cacoub P, Carrat F.

    Clin Chem. 2008 Aug;54(8):1372-8. Epub 2008 Jun 6.PMID: 18539647 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients.

    Bani-Sadr F, Miailhes P, Rosenthal E, Yazdanpanah Y, Boyer L, Zucman D, Cacoub P, Perronne C, Pol S, Carrat F; ANRS HC02 - Ribavic Study Team.

    AIDS. 2008 Jun 19;22(10):1234-6. No abstract available. PMID: 18525274 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.

    Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P.

    J Hepatol. 2008 May;48(5):765-73. Epub 2008 Feb 14.PMID: 18314219 [PubMed - indexed for MEDLINE]Related articles

    18.

    Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.

    Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P; French National Agency for Research on AIDS; Viral Hepatitis-HC02-Ribavic Study Team.

    Clin Infect Dis. 2008 Mar 1;46(5):768-74.PMID: 18248298 [PubMed - indexed for MEDLINE]Related articles

    19.

    Time lines of infection and disease in human influenza: a review of volunteer challenge studies.

    Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ.

    Am J Epidemiol. 2008 Apr 1;167(7):775-85. Epub 2008 Jan 29.PMID: 18230677 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.

    Chauvel O, Lacombe K, Bonnard P, Lascoux-Combe C, Molina JM, Miailhes P, Girard PM, Carrat F.

    Antivir Ther. 2007;12(7):1115-26.PMID: 18018770 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    5 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity